Session » Fibromyalgia and Other Clinical Pain Syndromes Poster

Date: Sunday, October 21, 2018

Time: 9:00AM-11:00AM

Meeting: 2018 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 244

A Qualitative Study Mapping the Behaviour Change Techniques Used in a Practice-Based Fibromyalgia Self-Management Programme

9:00AM-11:00AM: Abstract Number: 257

Argentine Registry of Patients with Fibromyalgia

9:00AM-11:00AM: Abstract Number: 258

Association of Sudoscan Values with Disease Duration in Female Patients with Fibromyalgia

9:00AM-11:00AM: Abstract Number: 242

DHEA Deficiency in Fibromyalgia

9:00AM-11:00AM: Abstract Number: 246

Factors Associated with Disability in a Prospective Cohort of Complex Regional Pain Syndrome Type 1

9:00AM-11:00AM: Abstract Number: 253

Fibromyalgia Patients Are Frequently Thought to be Challenging to Treat-Are They?

9:00AM-11:00AM: Abstract Number: 250

Fibromyalgia Patients Do Not Appear to Obsess about Their Symptoms Compared with Other Rheumatic Disease Patients

9:00AM-11:00AM: Abstract Number: 247

Fibromyalgia Patients Often Receive Several Rheumatic Disease Diagnoses

9:00AM-11:00AM: Abstract Number: 243

High Prevalence of Fibromyalgia Among Israel School Teachers

9:00AM-11:00AM: Abstract Number: 245

Improvement in Fibromyalgia Symptoms and Skin Biopsy Results in Patients with Fibromyalgia and Small Fiber Neuropathy Treated with Intravenous Immune Globulin Infusion( IVIG)

9:00AM-11:00AM: Abstract Number: 255

Interpretation of Proverbs Compared with the Mental Clutter Scale in Fibromyalgia Patients Demonstrates Intact Intellectual Ability Despite the Symptoms of Fibrofog

9:00AM-11:00AM: Abstract Number: 241

Is There a Relationship between Takotsubo Cardiomyopathy and Fibromyalgia? Insights from the National Inpatient Sample Database

9:00AM-11:00AM: Abstract Number: 249

Patients with Fibromyalgia May be Fearful of Developing Dementia Despite Lack of Concrete Evidence of Cognitive Decline

9:00AM-11:00AM: Abstract Number: 259

Prevalence of Attention Deficit Hyperactivity Disorder Among Patients with Fibromyalgia

9:00AM-11:00AM: Abstract Number: 252

Publication Bias Regarding Scientific Studies about Fibromyalgia

9:00AM-11:00AM: Abstract Number: 256

The Effectiveness of Medications for Fibromyalgia Based on Patient Experiences

9:00AM-11:00AM: Abstract Number: 248

The Emotional Quotient in Fibromyalgia Patients Is Similar to Rheumatic Disease Controls

9:00AM-11:00AM: Abstract Number: 254

The Lumbar Spine Is Straight in Fibromyalgia Patients

9:00AM-11:00AM: Abstract Number: 251

Using the Stroop Word Naming Test and the Mental Clutter Scale in Fibromyalgia Patients to Evaluate the Symptoms of Fibrofog. in Office Testing of Cognitive Complaints

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].